Measuring the Benefits of Mass Vaccination Programs in the United States

Hector Magno, USA

Hector Magno is a researcher, data analyst, and software developer. He attended UC Berkeley as a Regent and Chancellor’s Scholar and earned a degree in Computer Science. He also attended UC Berkeley as a National Science Foundation fellow, earned a graduate degree in Computer Science and received the National Science Foundation Award in Mathematics.

The Induction of De Novo Autoimmune Biomarkers Production in Healthcare Professionals Vaccinated With BNT162b2

Maria Cristina Sacchi, SS Antonio and Biagio and C Arrigo Hospital, Italy

Dr. Maria Cristina Sacchi is a specialist in Clinical Pathology, Microbiology and Virology, holding a PhD in Molecular and Experimental Pathology and author of numerous national and international publications. Currently she is Head of the Laboratory of Autoimmunology of the Hospital of Alessandria. She carried out research activities, first at the Department of Medicine and Oncology of the University of Turin, then participating in the "Genome" Project under the guidance of Prof. Renato Dulbecco at the CNR of Milan and then dealt with cell cultures, in particular stem cells and bioengineering studies (tissue regeneration). He was Scientific Director of the multi-specialist group on "Platelet Gel", a new biotechnology (International Patent N. WO 01/43787 A2, Applicant and Inventor: Dr. Sacchi Maria Cristina) which is used in the treatment of surgical wounds and chronic ulcers (diabetic, vascular, decubitus and burns) and in oral, implant and maxillofacial surgery.

Data from Trimethoprim and Cotrimoxazole in Severe Covid-19 Lung Injury

Veronica A Varney, St Helier Hospital, UK

Immunological Profile of Children Aged 5 To 15 in the Health District of Ouahigouya after Introduction of the Menafrivac® Vaccine in 2010 in Burkina Faso

Mahamoudou Sanou, University Joseph KI - ZERBO, Ouagadougou, Burkina Faso.